Nofazinlimab (CS1003) is a human anti-PD-1 IgG4 monoclonal antibody used to study unresectable hepatocellular carcinoma (uHCC) and metastatic colorectal cancer.
Purity:
98.60%
CAS Number:
[2377845-98-0]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted